NuvaxovidTM COVID-19 Vaccine (recombinant, adjuvanted)
DISCLAIMER: THIS PAGE IS INTENDED FOR MEMBERS OF THE GENERAL PUBLIC IN SWITZERLAND ONLY.
The information provided on this site is intended for general information and education for Switzerland-based members of the public and is not intended to be a substitute for the advice provided by a physician or other qualified healthcare professional.
Nuvaxovid▼ dispersion for injection
Important information
For more information about the NuvaxovidTM dispersion for injection, view the PDF file of the Product monograph or the Patient information leaflet below.
If you have any questions or concerns regarding NuvaxovidTM dispersion for injection, please speak to your healthcare professional.
This link below will take you to download Patient information.
This link below will take you to download Product monograph.
If you are concerned about any potential side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the Patient Medication Information.
09:00 - 17:00
Monday - Friday
More information is available on our global website, novavax.com.
Our location:
Novavax CH GmbH
Fraumünsterstrasse 16
8001 Zürich
Switzerland